Science37 Decentralized Clinical Trial (DCT) Platform
(Redirected from Science 37’s Decentralized Clinical Trial Operating System)
A Science37 Decentralized Clinical Trial (DCT) Platform is a DCT SaaS provided by Science37.
- AKA: Science37 DCT OS.
- Context:
- It can support Fully-DCT.
- …
- Example(s):
- Counter-Example(s):
- See: Clinical Trial, Decentralized Clinical Trial, Telemedicine, Decentralized Research, Decentralized Computing, Decentralized Web, Decentralized System, Decentralization, Clinical Trials Transformation Initiative (CTTI), Association of Clinical Research Organizations (ACRO), COVID-19, Contract Research Organization (CRO), PPD Digital.
References
2021a
- (Science37, 2021) ⇒ https://www.science37.com/products#s1 Retrieved: 2021-09-26.
- QUOTE: Science 37’s Decentralized Clinical Trial Operating System is configurable to enable any type of study, in any indication. From fully Decentralized Clinical Trials to our Technology + (hybrid) model, our industry-leading platform can be customized to activate and operationalize even the most complex clinical trials.
2021b
- (Business Wire) ⇒ Businees Wire (2021). "PPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate Development. Innovative approach enables PPD to deploy studies utilizing Science 37's SaaS Platform".
- QUOTE: “Science 37 intends to be the operating system to enable all decentralized clinical trials”, said Steve Geffon, chief commercial officer of Science 37. “By enabling PPD Digital to utilize our innovative platform, we’re able to extend our reach and enable decentralization on more trials than ever before. Our new SaaS-based technology makes it easy to deploy Remote eConsent, eCOA, eSource and fully decentralized trials, even when it’s not part of the complete Science 37 DCT Operating System, which includes patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices.”